Polycystic Ovarian Syndrome in Adolescents

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Feb 27

PMID 36843701

Authors

Avanti Adone

Darshna G Fulmali

Affiliations

Soon will be listed here.

Abstract

Polycystic ovarian syndrome (PCOS) is a metabolic, reproductive, and psychological complex series of disorders that impacts a woman throughout her lifespan. PCOS is a disorder of hormonal imbalance occurring in women of reproductive age. This disorder is characterized by high levels of male androgens like testosterone. This can lead to symptoms like irregular periods, amenorrhea (absence of menstruation), anovulation (absence of ovulation), hirsutism, acne, and obesity. PCOS also causes metabolic impairment. Multiple peripherally arranged immature follicles of about 2-5mm in diameter are present in the ovary. These follicles do not mature due to hormonal imbalances leading to an irregular menstrual cycle. PCOS is a metabolic, reproductive, and psychological complex series of disorders that impacts a woman throughout her lifespan. Polycystic ovarian syndrome is not a fatal or life-threatening disorder as its main complication is infertility. PCOS can be a root cause of serious medical conditions like obesity, hypertension, type-2 diabetes mellitus due to insulin resistance, endometrial cancers, ovarian cancer, etc. Stress may cause the hormone levels in the pituitary to fluctuate. Since the menstrual cycle is hormone-based, there are apparent irregularities.

Citing Articles

The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial.

Mahmoudian A, Ashouri A, Rahmani Bilandi R, Mohammadzadeh F, Dashti S, Bahri N J Ovarian Res. 2024; 17(1):144.

PMID: 38997723 PMC: 11242022. DOI: 10.1186/s13048-024-01460-x.

ChatGPT's Efficacy in Queries Regarding Polycystic Ovary Syndrome and Treatment Strategies for Women Experiencing Infertility.

Devranoglu B, Gurbuz T, Gokmen O Diagnostics (Basel). 2024; 14(11).

PMID: 38893609 PMC: 11172366. DOI: 10.3390/diagnostics14111082.

Systematic exploration of network pharmacology, modeling and pharmacokinetic profiling for vitamin E in polycystic ovarian syndrome.

Begum R, Mohan S Future Sci OA. 2024; 10(1):FSO952.

PMID: 38817374 PMC: 11137767. DOI: 10.2144/fsoa-2023-0245.

Granulosa Cells-Related MicroRNAs in Ovarian Diseases: Mechanism, Facts and Perspectives.

Xiao S, Du J, Yuan G, Luo X, Song L Reprod Sci. 2024; 31(12):3635-3650.

PMID: 38594585 DOI: 10.1007/s43032-024-01523-w.

Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity.

Calcaterra V, Rossi V, Massini G, Casini F, Zuccotti G, Fabiano V Nutrients. 2023; 15(14).

PMID: 37513562 PMC: 10384396. DOI: 10.3390/nu15143144.

References

Parveen S, Das S . Homeopathic Treatment in Patients with Polycystic Ovarian Syndrome: A Case Series. Homeopathy. 2021; 110(3):186-193. DOI: 10.1055/s-0041-1725039. View

Ibanez L, Oberfield S, Witchel S, Auchus R, Chang R, Codner E . An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6):371-395. DOI: 10.1159/000479371. View

Dabadghao P . Polycystic ovary syndrome in adolescents. Best Pract Res Clin Endocrinol Metab. 2019; 33(3):101272. DOI: 10.1016/j.beem.2019.04.006. View

Williams R, Ong K, Dunger D . Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol. 2013; 373(1-2):61-7. DOI: 10.1016/j.mce.2013.01.005. View

Stener-Victorin E, Deng Q . Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol. 2021; 17(9):521-533. DOI: 10.1038/s41574-021-00517-x. View

Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G . Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril. 2007; 89(4):899-906. DOI: 10.1016/j.fertnstert.2007.04.043. View

Azziz R . Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 132(2):321-336. DOI: 10.1097/AOG.0000000000002698. View

Calcaterra V, Verduci E, Cena H, Magenes V, Todisco C, Tenuta E . Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients. 2021; 13(6). PMC: 8228678. DOI: 10.3390/nu13061848. View

Rothenberg S, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo J . Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2017; 48:103-114. DOI: 10.1016/j.bpobgyn.2017.08.008. View

10.

Bellver J, Rodriguez-Tabernero L, Robles A, Munoz E, Martinez F, Landeras J . Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2017; 35(1):25-39. PMC: 5758469. DOI: 10.1007/s10815-017-1047-7. View

11.

Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R . Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016; 106(1):6-15. DOI: 10.1016/j.fertnstert.2016.05.003. View

12.

Al Khalifah R, Florez I, Dennis B, Thabane L, Bassilious E . Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis. Pediatrics. 2016; 137(5). DOI: 10.1542/peds.2015-4089. View

13.

Pena A, Metz M . What is adolescent polycystic ovary syndrome?. J Paediatr Child Health. 2017; 54(4):351-355. DOI: 10.1111/jpc.13821. View

14.

Otto-Buczkowska E, Grzyb K, Jainta N . Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Pediatr Endocrinol Diabetes Metab. 2018; 24(1):40-44. DOI: 10.18544/PEDM-24.01.0101. View

15.

Fu L, Qu F, Pan J, Wang T, Wang F . Polycystic ovary syndrome in adolescents with obesity. Rev Assoc Med Bras (1992). 2021; 67(3):468-473. DOI: 10.1590/1806-9282.20200890. View

16.

Vosnakis C, Georgopoulos N, Rousso D, Mavromatidis G, Katsikis I, Roupas N . Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2012; 29(3):242-5. DOI: 10.3109/09513590.2012.736557. View

17.

Bremer A . Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010; 8(5):375-94. PMC: 3125559. DOI: 10.1089/met.2010.0039. View

18.

Gu Y, Zhou G, Zhou F, Wu Q, Ma C, Zhang Y . Life Modifications and PCOS: Old Story But New Tales. Front Endocrinol (Lausanne). 2022; 13:808898. PMC: 9045543. DOI: 10.3389/fendo.2022.808898. View

19.

Hamori M, Szendei G, Kovacs I, SOMOS P . [Relation between hyperprolactinemia and polycystic ovary syndrome]. Zentralbl Gynakol. 1987; 109(8):481-6. View

20.

Fazelian S, Rouhani M, Bank S, Amani R . Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis. J Trace Elem Med Biol. 2017; 42:92-96. DOI: 10.1016/j.jtemb.2017.04.008. View